Non-Hodgkin's lymphoma (NHL) is a type of cancer that affects the lymphatic system, which is part of the immune system. The survival rate for NHL depends on several factors such as the type and stage of the cancer, the patient’s age and overall health, and the treatment that is received.
Generally, the overall five-year survival rate for NHL is 69 percent. However, survival rates vary significantly by age. According to the American Cancer Society, for patients under the age of 45, the five-year survival rate for NHL is 89 percent. For those between the ages of 45 and 54, the survival rate decreases slightly to 73 percent. For those between the ages of 55 and 64, the survival rate is 63 percent, and for those over the age of 65, the survival rate is 57 percent.
It is important to note that these survival rates are estimates and that every individual’s situation is unique. The age-specific survival rates for NHL are based on data from people diagnosed between 2006 and 2012. As treatments and therapies for NHL improve over time, the survival rates for each age group may also improve.
Overall, the survival rate for NHL is high, but it does decrease with increasing age. It is essential that people of all ages be aware of the signs and symptoms of NHL and seek prompt medical attention if any of them are present.